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Huntington’s Disease is an inherited neurodegenera-
tive disease that affects the medium spiny neurons in
the striatum. The disease is caused by the expansion of
a polyglutamine sequence in the N terminus of Hunting-
tin (Htt), a widely expressed protein. Recently, we have
found that Htt is an antiapoptotic protein in striatal
cells and acts by preventing caspase-3 activity. Here we
report that Htt overexpression in other CNS-derived
cells can protect them from more than 20 days exposure
to fatal stimuli. In particular, we found that cytochrome
c continues to be released from mitochondria into the
cytosol of cells that overexpress normal Htt. However,
procaspase-9 is not processed, indicating that wild-type
Htt (wtHtt) acts downstream of cytochrome c release.
These data show that Htt inhibits neuronal cell death by
interfering with the activity of the apoptosome complex.
Huntingtin is a protein that is enriched in neurons and
exerts a function in the control of neuronal survival and sta-
bility (1). Interest in this protein derives from the fact that an
expanded polyglutamine (poly(Gln)) tract in its N terminus
causes Huntington’s Disease (HD),1 a neurological disorder
associated with the selective loss of striatal and cortical neu-
rons (2). It is well documented that the extended poly(Gln)
stretch in Htt confers a deleterious gain-of-function to the
protein. More recently, the hypothesis that loss of normal Htt
function might contribute to the disease has gained strong
support from studies reporting a number of beneficial functions
of this protein in CNS cells (Refs. 3–5; reviewed in Ref. 1). In
addition, Ona et al. (6) demonstrate that in HD transgenic mice
there is a depletion of endogenous Htt.
Early studies indicate that Htt serves important functions
during normal embryonic development, because homozygous
knockout mice die by day 7.5 (7–9). On the other hand, recent
findings obtained in adult mice where conditional inactivation
of wild-type Htt was elicited in mature neurons demonstrate
degeneration of axon fibers and evident signs of apoptosis,
which were accompanied by neurological dysfunctions similar
to those observed in current transgenic mouse models of HD
(5). More direct evidence of Htt function in cell survival was
provided for the first time by a study from our group, where
conditionally immortalized striatal derived ST14A cells engi-
neered to express the normal or mutant protein were exposed
to various apoptotic stimuli such as serum withdrawal, 3-ni-
troproprionic acid, or transfection of death genes (4). We found
that these stimuli triggered apoptotic death in parental ST14A
cells but were ineffective in ST14A derivatives expressing ei-
ther the FL or an N terminus 548-amino acid truncation of the
wild-type Htt (FLwt and N548wt, respectively). As expected,
an increased propensity for death was observed in subclones
expressing mutant Htt. A subsequent report suggests that the
Htt antiapoptotic effect occurs via sequestration of the HIP1
proapoptotic molecule (10). Other investigations imply a role
for Htt in protein-protein interactions, modulation of gene
transcription as well as in retrograde and fast axonal trans-
port, and nuclear-cytoplasmic shuttling (for reviews, see Refs. 1
and 11). Taken together, these data indicate that Htt exerts
important effects on neuronal cell survival and stability. We
have also reported that wtHtt cells are protected from apopto-
sis induced by caspase-9 transfection (4). These data, combined
with the reduced activity of caspase-3 and evidence that the
same cells are killed by transfection of a constitutively active
form of caspase-3, suggest strongly that wtHtt acts upstream of
caspase-3, probably at the level of caspase-9 (4).
Here we show that Htt’s neuroprotective activity does not
occur via blockade of cytochrome c release from the mitochon-
dria, but rather through inhibition of cytochrome c-dependent
procaspase-9 processing and activity. One hypothesis is that
Htt modulates the activity of the apoptosome complex by in-
teracting with one of the apoptosome components. Finally, we
report that Htt permanently protects CNS cells from toxic
insults and that this effect occurs in several different CNS-
derived cells.
EXPERIMENTAL PROCEDURES
Cell Culture and MTT Assay—Conditionally immortalized striatal-
derived ST14A cells and subclones previously engineered to overex-
press the full-length wild-type (FLwt) or full-length mutant (FLmu)
proteins or an amino terminus 548-amino acid portion of Huntingtin
(N548) in the wild-type or mutant versions (N548wt or N548mu cells,
respectively) were utilized in this study and grown as described
previously (4). The different clones express the exogenous normal or
mutant Huntingtin at a similar level (4). Hippocampal-derived HiB5
cells (12) were grown at 33 °C in the presence of Dulbecco’s modified
Eagle’s medium (4). L929 cells and derivatives were grown at 37 °C in
complete medium. Chemically defined serum-free medium (SDM)
was prepared as described (4). Infection was performed using medium
conditioned from RetroPack PT67 Cell Line (CLONTECH) stably
transfected with the cDNA of interest and according to previously
described procedures (13). The MTT assay was performed as de-
scribed previously (4).
Measurement of Caspase-9 and Caspase-8 Activities—Samples of
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1–2 3 106 cells were rinsed in cold phosphate-buffered saline, lysed,
and stored as described (4). Lysates were then incubated at 37 °C in
buffer supplemented with substrate LEHD-7-amino-4-trifluoro-
methyl coumarin (afc) (25 mM) for caspase-9 or IETD-afc (25 mM) for
caspase-8. Release of the fluorogenic afc moiety and protein contents
were quantified as described previously (4). To assess specificity,
caspase-9 and caspase-8 inhibitors were utilized (Z-LEHD-FMK and
Z-LETD-FMK, respectively). Where indicated, 5 nM cytochrome c was
added.
Cell Fractionation—ST14A cells and subclones overexpressing FLwt
or FLmu were plated onto 100-mm dishes. At 80% confluence, cells were
exposed to SDM for 4 h at 39 °C, and the cytosolic and mitochondrial
fractions were prepared according to a protocol kindly provided by Dr.
T. Greenamyre and Dr. A. Panov. Briefly, cells were lysed in a hypotonic
buffer and homogenized, and tonicity was adjusted to 250 mosM. Sub-
sequent centrifugations at 9,300 3 g pelleted the mitochondrial frac-
tion. The supernatant was centrifuged at 100,000 3 g to obtain the
cytosolic fraction.
Western Blot Analyses—Total cellular lysates were obtained with a
hypotonic buffer containing Triton (0.5%). The blotted proteins were
exposed to anti-Htt mAb2166 (dilution 1:5000, Chemicon) or anti-cyto-
chrome c (dilution 1:2000, PharMingen) antibodies.
Procaspase-9 Processing—Five 150-mm dishes of cells at 90%
confluence were lysed with Buffer A. The lysates were centrifuged
at 100,000 3 g to obtain the S-100 fraction. 35S-Labeled procaspase-9
was prepared using the TNT-quick in vitro-transcription/translation
kit (Promega). In the assay, 20 mg of S-100 extracts were incubated
with 35S-procaspase-9, 1 mM dATP, and increasing amounts of
cytochrome c at 37 °C for 30 min. Reactions were run on
12% SDS-PAGE, and the dried gel was autoradiographed. Statistical
analyses were performed by analysis of variance test as described
in Rigamonti et al. (4).
RESULTS
Permanent Inhibition of Cell Death by Htt Expression in
Various CNS Cell Types—ST14A cells (14), which are immor-
talized with the temperature sensitive oncogene Large T-Anti-
gen, stop dividing at the non-permissive temperature (39 °C),
tend to differentiate, and, in chemically defined SDM undergo
apoptotic cell death. ST14A subclones stably transfected with
wtHtt cDNA are protected from this death stimulus (4). Yet,
protection by Htt was drastically reduced after 120 h of expo-
sure to this condition as a consequence of the disappearance of
the exogenous protein (4). Therefore, the possibility of a per-
manent, long term protective effect of Htt in these engineered
striatal cells could not be properly assessed.
We have now obtained a new generation of subclones of
striatal ST14A cells where the expression of the transgene
remains constant with time of exposure at the non-permissive
temperature. N548wt cDNA was retrovirally transduced into
ST14A cells because it reproduces fully the effect of the FL
protein. Fig. 1A shows a Western blot analysis of lysates ob-
tained from wtHtt cells that were exposed to 39 °C in SDM for
0, 5, 15, and 20 days. As shown, N548wt Htt expression re-
FIG. 1. Huntingtin protects CNS cells from lengthy exposure to apoptotic stimuli. A, Western blot analyses showing permanent
expression of N548wt Htt in the newly generated ST14A subclones exposed for 0, 5, 15, and 20 days to apoptotic insults (SDM at 39 °C). B, MTT
assay, ST14A cells (M), and two N548wt infected subclones, iN548–32 (E) and iN548wt-36 (L), were exposed to the same conditions as in A. Cell
survival was monitored at the times indicated. Parental ST14A cells gradually underwent apoptotic cell death. By contrast, cells overexpressing
wild-type Htt survived over 20 days of exposure to this condition. The graph shows the mean 6 S.D. of four independent assays. The same data
were obtained when cell viability was measured using a Coulter Counter machine (not shown; Ref. 4). C, MTT assay, 3-nitropropionic acid was
added for 48 h to wtHtt cells after a 20-day exposure under conditions described in A. Protection from death induced by this toxin was observed
in both clones expressing wtHtt. Treatment of parental cells with 3-nitropropionic acid normally leads to cell death. Indeed, in a parallel
experiment, 3-nitropropionic acid evoked dose-dependent death of parental ST14A cells in normal growth conditions (not shown; Ref. 4). D,
hippocampal-derived HiB5 cells were retrovirally transduced with N548wt and exposed to the same experimental paradigm as in A. Expression
of the transgene was confirmed by Western blot (not shown). In the graph, wtHtt-HiB5 cells (E) were protected from death with respect to parental
HiB5 cells (M). E, improved viability of wtHtt-HiB5 cells following 3-nitropropionic acid exposure. MTT assay, 48-h time point; *, p , 0.05 and **,
p , 0.001 with respect to parental cells. F, L929 cells overexpressing N548wt (wtHtt-L929 cells) were not protected from a 24-h exposure to
different doses of TNF. Inset, Western blot showing N548wt protein expression in one of the engineered L929 subclones (lane 2), and no
immunoreactivity in parental cells (lane 1).
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mained stable over time.
In these new ST14A subclones (Fig. 1B, iN548wt-32 (E) and
iN548wt-36 (L), permanent protection from the apoptotic in-
sult occurs even after a 20-day exposure to these conditions. In
the figure, parental ST14A cells show the typical decrease in
cell survival with time at 39 °C (M). Furthermore, application
of 3-nitropropionic acid at that time point (20 days at 39 °C) did
not evoke death in iN548wt-32 and iN548wt-36 cells (Fig. 1C),
confirming a permanent antiapoptotic effect of the exogenous
wtHtt. In a control experiment, 3-nitropropionic acid evoked
dose-dependent cell death in parental ST14A cells grown in
normal passaging conditions (data not shown; Ref. 4).
To determine whether the antiapoptotic effect of Htt was
specific for the striatal-derived cells, the N548wt cDNA was
also expressed in hippocampal cells HiB5, fibroblast 3T3 cells,
and fibrosarcoma L929 cells. Whereas overexpression of Htt in
HiB5 cells confirmed the protective effect from SDM (Fig. 1D)
or 3-nitropropionic acid exposures (Fig. 1E), no protection was
seen in 3T3 derivatives with stable expression of wtHtt treated
with 3-nitropropionic acid (data not shown) or in N548wt-
expressing subclones of L929 cells exposed to tumor necrosis
factor (TNF) (Fig. 1F). In these same conditions, no changes in
caspase-8 activity were detected in N548wt L929 cells with
respect to parental cells (data not shown).
Decreased Basal and Cytochrome c-stimulated Caspase-9 Ac-
tivity in FLwt Cells—We have previously shown that wtHtt
protects from apoptosis upstream of caspase-3 and downstream
of proapoptotic Bcl-2 family members BIK and BAK (4). Also,
the toxicity that follows transfection of procaspase-9 in paren-
tal ST14A cells is prevented by expression of wtHtt (4). On this
basis, we hypothesized that the molecular target of Htt neuro-
protective action lies at the level of caspase-9.
We therefore analyzed the effect of the temperature shift on
the activity of caspase-9 by monitoring the release of the flu-
orogenic afc moiety from the caspase-9 substrate LEHD-afc in
the absence or presence of exogenous cytochrome c. In Fig. 2A,
parental ST14A cells (M) show an increased release of the
fluorogenic moiety over time, which, as expected, is enhanced
in FLmu cells (E). In contrast, release of the fluorogenic moiety
is completely inhibited in FLwt cells (Fig. 2A, L) even at 12 h.
This effect appears to be modulated by cytochrome c, because
addition of exogenous cytochrome c after 3 h of permanence at
39 °C increased greatly the levels of caspase-9 activation in
ST14A cells (Fig. 2B). Nevertheless, FLwt cells showed no
caspase-9 activity even when exogenous cytochrome c was
added (Fig. 2B).
We concluded that wild-type Htt exerts its antiapoptotic
effect by modulating a step upstream of caspase-9 activation.
Huntingtin’s Antiapoptotic Effect Occurs Downstream of Mi-
tochondrial Cytochrome c Release—We previously reported
that wtHtt cells are protected from the action of proapoptotic
Bcl-2 homologs, implying that Htt acts on mitochondrial or
postmitochondrial apoptotic events (4). To evaluate whether
inhibition of caspase-9 activity in wtHtt cells is caused by
impaired cytochrome c release from the mitochondria, we an-
alyzed levels of cytosolic cytochrome c in parental, FLwt, and
FLmu cells. Cells were exposed to SDM at 39 °C, and the
cytosolic and mitochondrial fractions were prepared. As shown
in Fig. 3, under normal growth conditions most of the cyto-
chrome c is found in the mitochondrial fraction. Indeed, a
Western analysis of the cytosolic fraction from parental and
FLwt cells was negative for cytochrome c. Interestingly, in the
same normal passaging conditions, cytochrome c was found in
the cytosol of FLmu cells. Notably, however, exposure of the
cells to a death stimulus like SDM at 39 °C for 4 h evoked a
similar release of cytochrome c from the mitochondria of pa-
rental and FLwt cells (Fig. 3). We concluded that Htt protective
activity does not involve inhibition of cytochrome c release from
the mitochondria.
WtHtt Inhibits Cleavage of Procaspase-9—Release of cyto-
chrome c from mitochondria by apoptotic signals induces ATP/
dATP-dependent formation of the apoptosome complex, with
subsequent autoprocessing of procaspase-9 into its two active
fragments (15). Because our data demonstrate inhibition of
caspase-9 activity in the presence of cytochrome c in the cyto-
solic fraction of wtHtt cells, we reasoned that Htt could play a
role in caspase-9 processing. To this end, in vitro caspase-9
FIG. 2. Inhibition of caspase-9 activity in FLwt cells. The release
of the fluorogenic afc moiety from the caspase-9 substrate LEHD-afc is
reported at various time points (0, 3, 9, and 12 h) following the temper-
ature shift (A) and before or after cytochrome c addition to the lysates
(B). A, time 0, basal levels of caspase-9 activity in normal growth
conditions, i.e. 33 °C. After exposure to SDM at 39 °C, parental ST14A
cells (M) showed an increased caspase-9 activity. Higher activity was
observed in Flmu cells (E). In contrast, Flwt cells (L) showed no
caspase-9 activity, even at 12 h after the temperature shift. Data are
expressed as nmols of cleaved substrate. One experiment is shown of
five performed on different clones that gave similar results. B, at 3 h
after the temperature shift, cellular extracts were exposed to LEHD-afc
in the presence of cytochrome c. In treated lysates, an increased release
of the fluorogenic moiety was observed. In contrast, no caspase-9 activ-
ity was detected in cytochrome c-triggered FLwt cells.
FIG. 3. Cytochrome c is found in the cytoplasm of FLwt cells
that survived. Western blot analysis was performed on the mitochon-
drial and cytosolic fractions obtained from cells grown in normal pas-
saging conditions, i.e. 33 °C (basal conditions) and after a 4-h incuba-
tion in SDM at 39 °C (SDM). The protocol used and described under
“Experimental Procedures” was the one that gave the best and most
reproducible subfractionations of the four protocols utilized. Under
basal conditions, cytochrome c remained within the mitochondria in
parental (lane 1) and FLwt (lane 2) cells. Instead, leakage of cytochrome
c from the mitochondria of Flmu cells was observed as revealed in the
blot of the cytosolic fraction (lane 3). At 4 h after the temperature shift
(SDM), cytochrome c was entirely localized to the cytosol of all cell
clones. Notably, this ability was also maintained in FLwt cells. Tubulin
reactivity in the same preparations is shown. Column bars, the inten-
sity of the immunoreactive bands.
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cleavage assays were performed (16). S-100 extracts from pa-
rental ST14A cells, N548wt, FLwt, N548mu, and Flmu cells
were incubated with 35S-labeled in vitro transcribed/translated
procaspase-9, and increasing amounts (0.4, 4, 40 ng/ml) of cy-
tochrome c. Fig. 4 shows that the appearance of the two active
fragments from the inactive 48-kDa procaspase-9 in parental
ST14A cells is cytochrome c concentration-dependent. In par-
ticular, no processing is observed at the lower concentration of
0.4 ng/ml. In contrast, at that same dose, N548mu and FLmu
cells were able to process procaspase-9. Thus, we also demon-
strate that N548wt and FLwt cells process procaspase-9 less
efficiently than parental cells, even at the maximal concentra-
tion of cytochrome c utilized in our study. We conclude that
wtHtt exerts its antiapoptotic role by interfering with cyto-
chrome c-dependent procaspase-9 processing.
DISCUSSION
In our previous report we demonstrated that Htt prevents
apoptosis of striatal cells (4). This evidence, combined with
more recent data from other authors, together suggest that loss
of Htt function plays a role in HD (1).
The mechanisms by which Htt exerts this protective effect is
also beginning to be elucidated. We previously found that Htt
acts upstream of caspase-3 and downstream of proapoptotic
Bcl2-members (4). Here we report an inhibition of caspase-9
activity in cells expressing wtHtt. We also report that cyto-
chrome c redistributes normally into the cytosol of wtHtt cells
exposed to apoptotic insults. However, these cells do not un-
dergo cell death (4). During apoptosis cytochrome c release
from mitochondria yields to recruitment of Apaf-1 and process-
ing of procaspase-9 into its two active fragments. We demon-
strate that wild-type Htt exerts a negative effect on cytochrome
c-dependent processing of procaspase-9. As expected, process-
ing of procaspase-9 occurs more efficiently in mutant Htt cells,
leading to increased caspase-3 activation; the latter result was
reported in several studies (4, 17). We also show that cells
expressing the mutation have a basal leakage of cytochrome c,
which may reflect an acquired activity of mutant Htt at a
mitochondrial or premitochondrial level. These data are in
agreement with data showing caspase-1 and caspase-8 involve-
ment in HD (6, 18) and with the demonstration of cytochrome
c leakage in PC12 cells expressing the exon 1 portion of mutant
Htt (19).
Based on the described activities of Htt, we also hypothesize
that the wild-type protein functions to counteract caspase-9
activation either by binding to it directly or via inhibition of the
apoptosome complex formation. In particular, Htt appears spe-
cifically to inhibit an apoptotic pathway, which is likely the
most active death pathway in CNS cells. In fact, we found that
Htt does not interfere with another apoptotic death pathway,
which is caspase-8 mediated. These data reinforce the hypoth-
esis that Htt plays a key role in CNS cells. As a matter of fact,
we found that Htt is equally neuroprotective in a number of
different CNS-derived cells. We also found that cells expressing
exogenous Htt do not die even after lengthy exposure to apo-
ptotic insults. Such an effect is of potential therapeutical value,
as strategies aimed at restoring or increasing normal Htt levels
or activities in cells would be relevant for HD and other neu-
rodegenerative diseases.
Taken together, these data imply that Htt plays an impor-
tant role in the formation and/or function of the apoptosome
complex, the controlled activity of which is crucial for proper
CNS cell survival. At the same time, our findings argue
strongly in favor of the possibility that loss of neuroprotective
Htt function occurs in HD, with resulting increased vulnera-
bility of CNS neurons (reviewed in Ref. 1).
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